Great Valley Advisor Group Inc. Has $378,000 Stock Position in iShares Biotechnology ETF (NASDAQ:IBB)

Great Valley Advisor Group Inc. lifted its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 14.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,786 shares of the financial services provider’s stock after purchasing an additional 344 shares during the quarter. Great Valley Advisor Group Inc.’s holdings in iShares Biotechnology ETF were worth $378,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of IBB. Bank of New York Mellon Corp lifted its position in shares of iShares Biotechnology ETF by 3.5% during the 3rd quarter. Bank of New York Mellon Corp now owns 21,146 shares of the financial services provider’s stock worth $2,586,000 after buying an additional 716 shares during the last quarter. Macroview Investment Management LLC lifted its position in shares of iShares Biotechnology ETF by 5,340.0% during the 3rd quarter. Macroview Investment Management LLC now owns 544 shares of the financial services provider’s stock worth $67,000 after buying an additional 534 shares during the last quarter. Park Avenue Securities LLC bought a new stake in shares of iShares Biotechnology ETF during the 3rd quarter worth $238,000. CENTRAL TRUST Co raised its position in iShares Biotechnology ETF by 1.2% in the third quarter. CENTRAL TRUST Co now owns 14,838 shares of the financial services provider’s stock valued at $1,815,000 after purchasing an additional 174 shares during the last quarter. Finally, Whittier Trust Co. raised its position in iShares Biotechnology ETF by 26.4% in the third quarter. Whittier Trust Co. now owns 6,471 shares of the financial services provider’s stock valued at $791,000 after purchasing an additional 1,350 shares during the last quarter. 62.45% of the stock is owned by institutional investors and hedge funds.

iShares Biotechnology ETF Trading Up 1.8 %

iShares Biotechnology ETF stock opened at $132.96 on Monday. iShares Biotechnology ETF has a 12 month low of $111.83 and a 12 month high of $141.16. The stock has a 50-day moving average price of $133.61 and a two-hundred day moving average price of $130.12.

iShares Biotechnology ETF Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 27th. Stockholders of record on Friday, March 22nd were given a dividend of $0.126 per share. The ex-dividend date was Thursday, March 21st. This represents a $0.50 dividend on an annualized basis and a dividend yield of 0.38%.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.